30 March 2024 in Ophthalmology Retina
10 December 2025 in American Journal of Ophthalmology Case Reports
Intermediate Junctional Epidermolysis Bullosa (JEB) is an extremely rare condition, with an incidence of slightly more than two per million live births. Patients with Epidermolysis Bullosa are classified using the “onion skinning” approach, which includes the major EB type, phenotypic characteristics, inheritance mode, targeted protein and its skin expression, gene involved, mutation types, and specific mutation(s) and location. This facilitates recognition of syndromic EB and aids in genetic counseling. To report a patient with Intermediate JEB, perform a detailed ophthalmic evaluation, and identify the genetic cause through testing. A 13-year-old girl presented with recurrent epithelial erosions since 2015, with minimal or no trauma. Ophthalmic exam revealed bilateral faint corneal opacities and prominent corneal innervation. Systemic findings included hypodontia and hypopigmentation of the forearms and retroauricular region. Whole exome sequencing revealed a homozygous c.2137+2T > G variant in the LAMB3 gene, likely disrupting mRNA splicing by altering the donor splice site. This mutation is expected to cause a frameshift and dysfunctional protein product. It was confirmed by Sanger sequencing. The ocular, dental, and dermal findings support a diagnosis of EB, highlighting the importance of multidisciplinary evaluation. Identification of this novel LAMB3 variant expands the known genotypic spectrum of JEB and enhances understanding of its molecular basis. This contributes to accurate diagnosis and improved genetic counseling for affected families.
7 August 2026 in American Journal of Ophthalmology Case Reports
23 March 2025 in American Journal of Ophthalmology Case Reports
To document a rare case of congenital aniridia due to paired box gene 6 (PAX6), elongated protein 4 (ELP4) and fusion gene DKFZp686k1684 mutation with bilateral congenital lacrimal gland agenesis and multiple ocular comorbidities, aiming to expand the understanding of its clinical presentations and therapeutic interventions. A 10-year-old female presented with severe dry eyes and photophobia, with no tears since birth in both eyes. Diagnosed with sporadic aniridia, previously the patient developed secondary glaucoma requiring multiple surgeries in both eyes. Examination revealed severe dry eyes, foveal hypoplasia, aniridia-associated keratopathy, and was suspicious for absence of lacrimal gland with no palpebral lobe evident on bilateral external inspection. Magnetic resonance imaging revealed lacrimal gland hypoplasia of the right eye and lacrimal gland agenesis of the left eye. Over 10 years, the patients’ condition was managed with punctal plugs and artificial tears allowing for stable vision with resolution of bilateral superficial punctate keratitis. Whole genome sequence analysis revealed a large deletion in chromosome 11p13 including the whole PAX6 gene, ELP4 and fusion gene DKFZp686k1684. This case illustrates an association between congenital aniridia and lacrimal gland agenesis. The findings highlight the complexity of genetic influences on ocular development and the importance of early identification and management to prevent complications.
29 August 2026 in AJO International